Ranitidine belongs to a class of drugs known as H2 receptor antagonists, or H2 blockers [1]. These medications work by decreasing the amount of acid produced by the stomach [1][2].
What is the primary use of ranitidine?
Ranitidine is primarily used to treat and prevent ulcers in the stomach and intestines [1][3]. It is also prescribed to manage gastroesophageal reflux disease (GERD), a condition where stomach acid flows back into the esophagus, causing heartburn and other symptoms [1][3]. Additionally, it can be used to treat conditions where the stomach produces too much acid, such as Zollinger-Ellison syndrome [1][3].
What other drugs are in the H2 blocker class?
Other H2 blockers include famotidine, cimetidine, and nizatidine [2][4]. These drugs function similarly by blocking histamine's action on the stomach's parietal cells, thereby reducing acid secretion [2].
What happened with ranitidine products?
In 2020, the U.S. Food and Drug Administration (FDA) requested that all prescription and over-the-counter (OTC) ranitidine products be removed from the market [5]. This action was taken due to the presence of a probable human carcinogen, N-Nitrosodimethylamine (NDMA), found in ranitidine products [5]. While NDMA is also found in some foods and water, the levels detected in ranitidine were deemed unacceptable [5].
Are there alternatives to ranitidine?
Yes, several alternatives are available for conditions previously treated with ranitidine. These include other H2 blockers like famotidine and nizatidine, as well as proton pump inhibitors (PPIs) such as omeprazole, lansoprazole, and esomeprazole [2][4]. Lifestyle modifications, including dietary changes and weight management, can also help manage acid-related conditions [3].
Where can I find more information on drug patents and exclusivity?
For detailed information on drug patents, patent expiry timelines, and exclusivity periods for various medications, DrugPatentWatch.com offers extensive resources [6].
---
Sources:
1. https://medlineplus.gov/druginfo/meds/a681011.html
2. https://www.nhs.uk/conditions/acid-reflux/treatment/
3. https://www.mayoclinic.org/drugs-supplements/ranitidine-oral-route-parenteral-route/usage/drg-20067842
4. https://www.webmd.com/drugs/2/index
5. https://www.fda.gov/drugs/drug-safety-and-availability/fda-nprm-ranitidine-all-product-sizes-and-formulations-removed-market
6. https://drugpatentwatch.com/